Valenza Franco, Bottino Nicola, Canavesi Katia, Lissoni Alfredo, Alongi Salvatore, Losappio Sabina, Carlesso Eleonora, Gattinoni Luciano
Istituto di Anestesia e Rianimazione, Ospedale Maggiore di Milano-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Università degli Studi di Milano, Via F. Sforza 35, 20122, Milan, Italy.
Intensive Care Med. 2003 Nov;29(11):2063-7. doi: 10.1007/s00134-003-2013-7. Epub 2003 Oct 7.
To investigate the possibility of artificially decreasing intra-abdominal pressure (IAP) by applying continuous negative pressure around the abdomen.
We investigated the effects of negative extra-abdominal pressure (NEXAP) on IAP and central venous pressure (CVP) in 30 patients admitted to our intensive care unit (age 57+/-17 years, BMI 26.1+/-4.0 kg/m2, SAPS II 41.8+/-17.0). Patients with severe hemodynamic instability and/or those admitted following a laparotomy were not studied. Measurements included bladder pressure as an estimate of IAP, CVP, invasive mean arterial pressure (MAP) and heart rate (HR). In five patients extensive hemodynamic measurements were also taken using a Swan-Ganz catheter. Following measurements at baseline (Basal), NEXAP (Life Care - Nev 100, Respironics) was applied on the abdomen, in random order, at a pressure equal to IAP (NEXAP0), 5 cmH(2)O (NEXAP-5) or 10 cmH(2)O (NEXAP-10) more negative than NEXAP0.
Basal IAP ranged from 4 to 22 mmHg. NEXAP decreased IAP from 8.7+/-4.3 mmHg to 6+/-4.2 (Basal vs NEXAP0 p<0.001). There was a further decrease of IAP when more negative pressure was applied: 4.3+/-3.2 mmHg, 3.8+/-3.7 mmHg (NEXAP-5 and NEXAP-10 vs NEXAP0, respectively, p<0.001). Similarly, CVP decreased from 9.3+/-3.4 mmHg to 7.5+/-3.8 (Basal vs NEXAP-10, p<0.001). The lower the IAP when NEXAP was applied, the lower the CVP (r2=0.778, p<0.001, multiple linear regression). When measured, cardiac output did not significantly change with NEXAP.
Negative extra-abdominal pressure may be applied in critically ill patients to decrease intra-abdominal pressure non-invasively.
探讨通过在腹部周围施加持续负压来人为降低腹腔内压力(IAP)的可能性。
我们研究了30例入住重症监护病房的患者(年龄57±17岁,体重指数26.1±4.0kg/m²,简化急性生理学评分II 41.8±17.0)的腹部外负压(NEXAP)对IAP和中心静脉压(CVP)的影响。未研究严重血流动力学不稳定的患者和/或剖腹手术后入院的患者。测量包括作为IAP估计值的膀胱压力、CVP、有创平均动脉压(MAP)和心率(HR)。在5例患者中,还使用Swan-Ganz导管进行了广泛的血流动力学测量。在基线(基础)测量后,以随机顺序在腹部施加NEXAP(Life Care - Nev 100,伟康公司),压力等于IAP(NEXAP0)、比NEXAP0更负压5cmH₂O(NEXAP-5)或10cmH₂O(NEXAP-10)。
基础IAP范围为4至22mmHg。NEXAP使IAP从8.7±4.3mmHg降至6±4.2mmHg(基础值与NEXAP0相比,p<0.001)。当施加更负压时,IAP进一步降低:分别为4.3±3.2mmHg、3.8±3.7mmHg(NEXAP-5和NEXAP-10与NEXAP0相比,p<0.001)。同样,CVP从9.3±3.4mmHg降至7.5±3.8mmHg(基础值与NEXAP-10相比,p<0.001)。施加NEXAP时IAP越低,CVP越低(r²=0.778,p<0.001,多元线性回归)。测量时,心输出量随NEXAP无显著变化。
腹部外负压可应用于危重病患者以无创降低腹腔内压力。